MiMedx Group Inc reports results for the quarter ended June 30 - Earnings Summary

MiMedx

29/07/2026 23:16

MiMedx Group Inc MDXG.OQ reported a quarterly adjusted loss of 5 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 10 cents.  The mean expectation of five analysts for the quarter was for a loss of 5 cents per share. Wall Street expected results to range from -6 cents to -3 cents per share.
Revenue fell 34.7% to $64.36 million from a year ago; analysts expected $63.46 million. 
MiMedx Group Inc's reported EPS for the quarter was a loss of 10 cents​.
The company reported a quarterly loss of $14.84 million.
MiMedx Group Inc shares had risen by 13.2% this quarter and lost 35.6% so far this year.
FORECAST CHANGES
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy" 
Wall Street's median 12-month price target for MiMedx Group Inc is $6.00, about 27.3% above its last closing price of $4.36
This summary was machine generated from LSEG data July 29 at 10:16 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-0.05
-0.05
Met
Mar. 31 2026 
-0.03
-0.07
Missed
Dec. 31 2025 
0.08
0.10
Beat
Sep. 30 2025 
0.07
0.15
Beat